Bulletin
Investor Alert

Tiziana Life Sciences Ltd.

NAS: TLSA

GO

Set Alerts

Market Index

Overview Profile Charts Financials Historical Quotes Analyst Estimates Options SEC Filings Insiders
/marketstate/country/us
Tiziana Life Sciences Ltd.

After Hours

 --Quotes are delayed by 20 min

Jun 9, 2023, 6:55 p.m.

TLSA
/zigman2/quotes/207307745/composite

$

0.74

Change

+0.0004 +0.05%

Volume

Volume 683

Quotes are delayed by 20 min

/zigman2/quotes/207307745/composite

Previous close

$ 0.76

$ 0.74

Change

-0.01 -1.64%

Day low

Day high

$0.74

$0.80

Open

52 week low

52 week high

$0.50

$1.39

Open
Income Statement Balance Sheet Cash Flow Statement

Annual Financials for Tiziana Life Sciences Ltd.

View Ratios
Fiscal year is January-December. All values USD millions. 20172018201920202021 5-year trend
Sales/Revenue -----
Cost of Goods Sold (COGS) incl. D&A 14,16616,001250,04589,765141,000
COGS excluding D&A -----
Depreciation & Amortization Expense 14,16616,001250,04589,765141,000
Depreciation 14,16616,001250,04589,765141,000
Amortization of Intangibles -----
Gross Income (14,166)(16,001)(250,045)(89,765)(141,000)
20172018201920202021 5-year trend
SG&A Expense 10.56M10.15M9.5M30.04M29.13M
Research & Development 6.02M5.51M3.71M5.98M13.21M
Other SG&A 4.54M4.64M5.79M24.05M15.92M
Other Operating Expense -----
Unusual Expense ---278,271-
EBIT after Unusual Expense ---(30.41M)-
Non Operating Income/Expense (45,070)296,020(164,570)2.42M2.79M
Non-Operating Interest Income --1,2767,694-
Equity in Affiliates (Pretax) -----
Interest Expense 11,59012,00193,129319,306176,000
Gross Interest Expense 11,59012,00193,129319,306176,000
Interest Capitalized -----
Pretax Income (10.63M)(9.88M)(10.01M)(28.3M)(26.66M)
Income Tax (1.91M)(1.95M)(688,899)(2.2M)(3.24M)
Income Tax - Current Domestic (1.91M)(1.95M)(688,899)(2.2M)(3.24M)
Income Tax - Current Foreign -----
Income Tax - Deferred Domestic -----
Income Tax - Deferred Foreign -----
Income Tax Credits -----
Equity in Affiliates -----
Other After Tax Income (Expense) -----
Consolidated Net Income (8.72M)(7.93M)(9.32M)(26.09M)(23.42M)
Minority Interest Expense -----
Net Income (8.72M)(7.93M)(9.32M)(26.09M)(23.42M)
Extraordinaries & Discontinued Operations -----
Extra Items & Gain/Loss Sale Of Assets -----
Cumulative Effect - Accounting Chg -----
Discontinued Operations -----
Net Income After Extraordinaries (8.72M)(7.93M)(9.32M)(26.09M)(23.42M)
Preferred Dividends -----
Net Income Available to Common (8.72M)(7.93M)(9.32M)(26.09M)(23.42M)
EPS (Basic) (0.08)(0.06)(0.07)(0.15)(0.24)
Basic Shares Outstanding 106.4M127.55M136.48M169.07M97.93M
EPS (Diluted) (0.08)(0.06)(0.07)(0.15)(0.24)
Diluted Shares Outstanding 106.4M127.55M136.48M169.07M97.93M
EBITDA (10.56M)(10.15M)(9.5M)(30.04M)(29.13M)
Copyright 2023 FactSet Research Systems Inc. All rights reserved. Source FactSet Fundamentals.
Link to MarketWatch's Slice.